Related references
Note: Only part of the references are listed.A multifactorial screening strategy to identify anti-idiotypic reagents for bioanalytical support of antibody therapeutics
Hossein Salimi-Moosavi et al.
ANALYTICAL BIOCHEMISTRY (2015)
Isolation of high-affinity, neutralizing anti-idiotype antibodies by phage and ribosome display for application in immunogenicity and pharmacokinetic analyses
Stacey E. Chin et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
A fit-for-purpose strategy for the risk-based immunogenicity testing of biotherapeutics: a European industry perspective
Cathelijne Kloks et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers
Christine Alewine et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Strategic characterization of anti-drug antibody responses for the assessment of clinical relevance and impact
Suzanna M. Tatarewicz et al.
BIOANALYSIS (2014)
Free analyte QC concept: a novel approach to prove correct quantification of free therapeutic protein drug/biomarker concentrations
Roland F. Staack et al.
BIOANALYSIS (2014)
How the bioanalytical scientist plays a key role in interdisciplinary project teams in the development of biotherapeutics: a reflection of the European Bioanalysis Forum
Sherri Dudal et al.
BIOANALYSIS (2014)
Theoretical Considerations and Practical Approaches to Address the Effect of Anti-drug Antibody (ADA) on Quantification of Biotherapeutics in Circulation
Marian Kelley et al.
AAPS JOURNAL (2013)
Characterization of murine anti-human Fab antibodies for use in an immunoassay for generic quantification of human Fab fragments in non-human serum samples including cynomolgus monkey samples
Kay Stubenrauch et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2013)
Mathematical simulations for bioanalytical assay development: the (un-)necessity and (im-)possibility of free drug quantification
Roland F. Staack et al.
BIOANALYSIS (2012)
Bioanalytical Approaches to Quantify Total and Free Therapeutic Antibodies and Their Targets: Technical Challenges and PK/PD Applications Over the Course of Drug Development
Jean W. Lee et al.
AAPS JOURNAL (2011)
Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies
Wolfgang Schaefer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Therapeutic monoclonal antibody concentration monitoring: free or total?
Bing Kuang et al.
BIOANALYSIS (2010)
A bioactive drug quantitation based approach for the detection of anti-drug neutralizing antibodies in human serum
Jenny Hu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates
Kay Stubenrauch et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies
Rafael Ponce et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2009)
Share Paper
